Načítá se...
Are we optimizing the use of dual antiplatelet therapy in patients hospitalized with acute myocardial infarction?
BACKGROUND: Dual antiplatelet therapy (DAPT) is a mainstay treatment for hospital survivors of an acute myocardial infarction (AMI). However, there are limited data on the prescribing patterns of DAPT among patients hospitalized with AMI during recent years. OBJECTIVE: To examine decade-long trends...
Uloženo v:
| Vydáno v: | Cardiovasc Revasc Med |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6824980/ https://ncbi.nlm.nih.gov/pubmed/31129036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.carrev.2019.04.024 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|